Characteristics of patients with sulphonurea-induced hypoglycemia
- PMID: 21450199
- DOI: 10.1016/j.jamda.2010.07.014
Characteristics of patients with sulphonurea-induced hypoglycemia
Abstract
Background/aim: Sulphonylurea (SU) agents continue to be a cornerstone of the therapy of type 2 diabetes mellitus (T2DM). Hypoglycemia is the most dangerous side effect of SU. Identifying the characteristics of patients with SU-induced hypoglycemia (SUIH) may help in reducing its frequency.
Methods: All consecutive admissions of patients with SUIH, between 2000 and 2008, were retrospectively reviewed.
Results: Over the study period, 4702 patients with type 2 diabetes mellitus were admitted to the department of medicine. Of these, 155 patients were admitted because of SUIH. Most of these patients were elderly, had multiple comorbid situations, and were taking multiple medications. Almost a third of the patients had a history of recent changes in the use of their medications. Various infectious complications (urinary, lung, skin, and peritoneal) occurred in 43% of patients. Renal failure was a frequent finding at admission (44% of patients had creatinine plasma levels > 120 μmol/L). Poor oral intake before admission was reported by 31% of patients. Markers of malnutrition (low serum levels of albumin, iron, vitamin B-12, and folic acid) were frequently found in most patients. Mean hemoglobin A1C levels were in the low abnormal levels. A major vascular event during hospitalization co-occurred in 11% of patients. Three patients died during the hospital admission for SUIH.
Conclusions: Elderly fragile patients with multiple comorbid situations including renal failure and tight glycemic control are prone to develop SUIH. Sulphonylurea agents should be avoided in such patients. An episode of SUIH should be considered as an alarming prognostic marker.
Copyright © 2012 American Medical Directors Association, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Predictors of relapse in elderly diabetic patients admitted with sulphonylurea-induced severe hypoglycaemic attacks.Age Ageing. 1997 Sep;26(5):409-10. Age Ageing. 1997. PMID: 9351488 No abstract available.
-
Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea.Curr Med Res Opin. 2012 May;28(5):731-6. doi: 10.1185/03007995.2012.681639. Epub 2012 Apr 24. Curr Med Res Opin. 2012. PMID: 22462528
-
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.Expert Opin Drug Saf. 2010 Sep;9(5):675-81. doi: 10.1517/14740338.2010.492777. Expert Opin Drug Saf. 2010. PMID: 20553106
-
Use of sulfonylurea agents in older diabetic patients.Clin Geriatr Med. 1990 Nov;6(4):903-21. Clin Geriatr Med. 1990. PMID: 2224754 Review.
-
[Hypoglycemia in the elderly with diabetes mellitus].Rev Invest Clin. 2010 Jul-Aug;62(4):366-74. Rev Invest Clin. 2010. PMID: 21222316 Review. Spanish.
Cited by
-
Rates and risk of hospitalisation among patients with type 2 diabetes: retrospective cohort study using the UK General Practice Research Database linked to English Hospital Episode Statistics.Int J Clin Pract. 2014 Jan;68(1):40-8. doi: 10.1111/ijcp.12265. Epub 2013 Sep 23. Int J Clin Pract. 2014. PMID: 24112108 Free PMC article.
-
Higher risk of sulfonylurea-associated hypoglycemic symptoms in women with type 2 diabetes mellitus.Clin Drug Investig. 2015 Sep;35(9):593-600. doi: 10.1007/s40261-015-0314-6. Clin Drug Investig. 2015. PMID: 26293520
-
Diabetes Management in Older Adults With Chronic Kidney Disease.Curr Diab Rep. 2019 Feb 15;19(3):11. doi: 10.1007/s11892-019-1128-3. Curr Diab Rep. 2019. PMID: 30771017 Free PMC article. Review.
-
Factors associated with prolonged length of stay in patients admitted with severe hypoglycaemia to a tertiary care hospital.Endocrinol Diabetes Metab. 2019 Mar 23;2(3):e00062. doi: 10.1002/edm2.62. eCollection 2019 Jul. Endocrinol Diabetes Metab. 2019. PMID: 31294080 Free PMC article.
-
Glycemic variability and cardiovascular disease in patients with type 2 diabetes.BMJ Open Diabetes Res Care. 2021 Mar;9(1):e002032. doi: 10.1136/bmjdrc-2020-002032. BMJ Open Diabetes Res Care. 2021. PMID: 33762313 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical